Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenomatous Polyposis Coli × guselkumab × Clear all

Phase

Status

No longer available 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Arthritis, Psoriatic 1 Adenomatous Polyposis Coli 1

Interventions

Celecoxib 4 Surveys and Questionnaires 2 Sulindac 2 Erlotinib Hydrochloride 2 Endoscopy 2 Eflornithine 2 Biopsy 2 guselkumab 1 Ursodeoxycholic Acid 1 Sirolimus 1 Sigmoidoscopy 1 Metformin 1 Lithium Carbonate 1 Gastroscopy 1 Endoscopy, Digestive System 1 Eicosapentaenoic Acid 1 Curcumin 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03649971 2025-02-03

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

Janssen Research & Development, LLC

Phase 1 Completed

Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡